Assessing Patients with Episodic Tension-Type Headache, Migraine or Chronic Daily Headache Using the Short Pain Inventory Andrew J. DowsonMichael BundyShaun G Kilminster Original Research Article 23 August 2012 Pages: 165 - 174
Evaluating the QT-Liability of a Drug during its Development Rashmi R. ShahJoel Morganroth Review Article 23 August 2012 Pages: 151 - 164
ABC of Bayesian Approaches to Drug Development Mark ChangAnthony Boral Current Opinion 23 August 2012 Pages: 141 - 150
Analysis of US Food and Drug Administration Warning Letters Maribel SalasMichelle MartinStephen P. Glasser Original Research Article 23 August 2012 Pages: 119 - 125
The Development of Herbal Medicinal Products Salvador CañigueralRoger TschoppOrlando Petrini Review Article 23 August 2012 Pages: 107 - 118
Ontological Analysis and Pathway Modelling in Drug Discovery Marc ZapatkaYvonne KochBenedikt Brors Review Article 23 August 2012 Pages: 99 - 105
Challenges in Combinational Oncology Studies Iain R. J. MacphersonJim Cassidy Review Article 23 August 2012 Pages: 85 - 97
Improving Drug Delivery in Paediatric Medicine Julia KrauseJörg Breitkreutz Review Article 23 August 2012 Pages: 41 - 50
Applications of Binding Kinetics to Drug Discovery David C. Swinney Current Opinion 23 August 2012 Pages: 23 - 34
Number Needed to Detect Manfred HaubenUlrich VogelFrancois Maignen Current Opinion 23 August 2012 Pages: 13 - 22
Incorporating Genome-Based Technologies into Toxicology and Safety Assessments for Drug Discovery and Development Lilian G. Yengi Review Article 24 August 2012 Pages: 427 - 438
Use of Risk Management Planning to Enhance Safety of Medicines Ian R. I. CarbarnsAndrew J. HudsonBarry D. C. Arnold Review Article 24 August 2012 Pages: 415 - 426
Informed Consent in Health Research Eike-Henner W. Kluge Review Article 24 August 2012 Pages: 405 - 414
Regulation of Therapeutic Research is Compromising the Interests of Patients Iain Chalmers Current Opinion 24 August 2012 Pages: 395 - 404
Setting Up an Internal Education Programme in Pharmaceutical Medicine Carl-David SundstedtAnthony J. Piraino Current Opinion 24 August 2012 Pages: 391 - 394
Drug Cost Development of Citalopram and Fluoxetine Following the Introduction of Generic Substitution in Finland Ville Aalto-SetäläRisto KanervaJ. Simon Bell Original Research Article 24 August 2012 Pages: 363 - 368
Safety Pharmacology Assessment Brian D. GuthPeter K. S. Siegl Current Opinion 24 August 2012 Pages: 357 - 361
Improving Decision-Making in Drug Development Using In Vitro Toxicology Screening Willi Suter Current Opinion 24 August 2012 Pages: 347 - 355
Is it Time to Revisit the Current R&D Model? Damian O’ConnellAndrew HopkinsDavid Roblin Current Opinion 24 August 2012 Pages: 339 - 345
The Impact of the Web and Standards on Clinical Trials David Iberson-Hurst Commentary 24 August 2012 Pages: 325 - 330
Data Mining in Pharmacovigilance Manfred HaubenDavid MadiganDonald J. O’Hara Commentary 24 August 2012 Pages: 319 - 323
Clinical Trials Registries and Results Reporting Francis P. Crawley Meeting Report 01 December 2012 Pages: 295 - 296
